Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q3 · 1,8 33 matched articles SCIE

Journal detail

Cerebrovascular Diseases

Publisher
S. Karger AG
Country
Switzerland · Western Europe
Type
journal
ISSN
  • 10159770
  • 14219786
Scopus 0,653 SJR
Scopus Q2 SJR Q
WoS Q3 JCR Q
WoS 1,8 JIF
Scopus 126 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,653
  • Quartile Q2
  • H-Index 126
  • Cites/doc 2,28
  • Docs (3y) 264
  • Cites (3y) 596

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 1,8
  • 5Y JIF 2,2
  • JCI 0,47

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Cardiology and Cardiovascular Medicine Q2
  • Medicine (miscellaneous) Q2
  • Neurology Q3
  • Neurology (clinical) Q2

Areas

  • Medicine
  • Neuroscience

WoS categories

  • Clinical Neurology | Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q3 0,653 1,8 2,2 0,47 Q3 126
2024 Q2 Q3 0,689 1,5 2,2 0,49 Q3 122
2023 Q2 Q3 0,7 2,2 2,5 0,58 Q2 122
2022 Q2 Q2 0,757 2,9 3,2 0,61 Q2 122
2021 Q2 Q3 0,834 3,1 3,6 0,61 Q2 122
2020 Q1 Q3 1,221 2,8 3,4 0,71 Q2 122
2019 Q1 Q2 1,168 2,7 3,1 0,77 Q2 122
2018 — Q2 — 2,7 3,1 0,86 Q1 —
2017 Q1 Q2 1,517 2,9 3,5 0,81 Q2 122
2016 Q1 Q2 1,618 3 3,4 — — 122
2015 Q1 Q1 1,69 3,4 3,3 — — 122
2014 Q1 Q1 1,846 3,8 3,5 — — 122
2013 Q1 Q1 1,848 3,7 3,5 — — 122
2012 Q1 Q2 1,723 2,8 3,2 — — 122
2011 Q1 Q2 1,645 2,7 2,8 — — 122
2010 Q1 Q2 1,525 3 3 — — 122
2009 — Q1 — 3,5 3,3 — — —
2008 — Q2 — 3 2,9 — — —
2007 — Q2 — 2,5 2,6 — — —
2006 — Q2 — 2 — — — —
2005 — Q2 — 2,3 — — — —
2004 — Q2 — 2,1 — — — —
2003 — Q2 — 2 — — — —
2002 — Q2 — 1,9 — — — —
2001 — Q2 — 1,7 — — — —
2000 — Q1 — 3 — — — —
1999 — Q2 — 1,7 — — — —
1998 — Q2 — 1,3 — — — —
1997 — Q2 — 1,6 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 CLINICAL NEUROLOGY SCIE Q3 Q3 213/296
2025 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 66/100
2024 CLINICAL NEUROLOGY SCIE Q4 Q3 215/286
2024 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 73/98
2023 CLINICAL NEUROLOGY SCIE Q3 Q3 156/280
2023 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 50/96
2022 CLINICAL NEUROLOGY SCIE Q3 Q3 116/212
2022 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 34/68
2021 CLINICAL NEUROLOGY SCIE Q3 Q3 126/212
2021 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 38/67
2020 CLINICAL NEUROLOGY SCIE Q3 Q3 133/208
2020 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 39/65
2019 CLINICAL NEUROLOGY SCIE Q2 Q2 98/204
2019 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 32/65
2018 CLINICAL NEUROLOGY SCIE Q2 Q2 96/199
2018 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q1 30/65
2017 CLINICAL NEUROLOGY SCIE Q2 Q2 81/197
2017 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 28/65
2016 CLINICAL NEUROLOGY SCIE Q2 — 71/194
2016 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 30/63
2015 CLINICAL NEUROLOGY SCIE Q2 — 54/193
2015 PERIPHERAL VASCULAR DISEASE SCIE Q1 — 15/63
2014 CLINICAL NEUROLOGY SCIE Q1 — 38/192
2014 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 16/60
2013 CLINICAL NEUROLOGY SCIE Q1 — 41/194
2013 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 17/65
2012 CLINICAL NEUROLOGY SCIE Q2 — 66/193
2012 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 27/68
2011 CLINICAL NEUROLOGY SCIE Q2 — 73/192
2011 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 24/68
2010 CLINICAL NEUROLOGY SCIE Q2 — 58/185
2010 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 20/68
2009 CLINICAL NEUROLOGY SCIE Q1 — 35/167
2009 PERIPHERAL VASCULAR DISEASE SCIE Q1 — 14/61
2008 CLINICAL NEUROLOGY SCIE Q2 — 41/156
2008 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 20/56
2007 CLINICAL NEUROLOGY SCIE Q2 — 49/146
2007 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 22/54
2006 CLINICAL NEUROLOGY SCIE Q2 — 68/147
2006 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 29/52
2005 CLINICAL NEUROLOGY SCIE Q2 — 52/148
2005 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 25/51
2004 CLINICAL NEUROLOGY SCIE Q2 — 51/140
2004 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 21/51
2003 CLINICAL NEUROLOGY SCIE Q2 — 50/135
2003 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 20/52
2002 CLINICAL NEUROLOGY SCIE Q2 — 52/138
2002 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 22/52
2001 CLINICAL NEUROLOGY SCIE Q2 — 46/136
2001 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 26/50
2000 CLINICAL NEUROLOGY SCIE Q1 — 19/137
2000 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 13/45
1999 CLINICAL NEUROLOGY SCIE Q2 — 50/132
1999 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 20/44
1998 CLINICAL NEUROLOGY SCIE Q2 — 53/125
1998 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 19/39
1997 CLINICAL NEUROLOGY SCIE Q2 — 38/107
1997 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 15/38